Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.56 USD | -0.57% | -10.46% | -2.61% |
Apr. 26 | Truist Lowers Price Target on AMERISAFE to $48 From $50, Keeps Hold Rating | MT |
Apr. 25 | Transcript : AMERISAFE, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Property & Casualty Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.61% | 871M | C | ||
+1.94% | 1.8B | B | ||
+11.15% | 85.6M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AMSF Stock
- Ratings AMERISAFE, Inc.